Chlamydia trachomatis infection in women living in remote areas in Amazonas, Brazil-a self-collection screening experience
Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Editora
SAGE PUBLICATIONS LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
ROCHA, Danielle A. P.
MORAES, Cassia de Oliveira
ARAUJO, Adriene F.
BELTRAO, Emille dos Santos
SANTOS, Lainara Castelo dos
MATA, Ligia Menezes da
XAVIER, Antonio N. N.
REIS, Renato dos Santos
SOARES, Silvia C. C.
TORRES, Katia L.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF STD & AIDS, v.30, n.4, p.336-343, 2019
Resumo
Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection among women. In Brazil, there is no organized screening program for C. trachomatis, and the actual prevalence of infection is unknown. This study aimed to determine the prevalence of C. trachomatis infection in women living in riverside communities in the Amazon, using self-collection employing the Evalyn (R) Brush and polymerase chain reaction. A total of 299 riverine women aged 18-81 years, mean age 35.7 (+/- 12.8) years, predominantly agricultural workers, with low schooling and living with a partner, participated in this study. The prevalence of C. trachomatis infection was found to be 3.7% (95% CI 1.8-6.5), most of them being symptomatic. The mean age of the first sexual intercourse reported by women was 15.2 (+/- 2.3) years, and the majority reported having had none or only one partner in the last 12 months, with very low adherence to consistent condom use (15.4%). Most women (98.3%) reported having approved using the vaginal self-collecting brush, and only 4.7% reported having difficulty in handling the brush. We consider that a vaginal self-collecting device is adequate for diagnosing C. trachomatis infection in women living in remote, hard-to-reach areas.
Palavras-chave
Chlamydia (Chlamydia trachomatis), South America, epidemiology
Referências
- Barcelos MRB, 2008, REV BRAS GINECOL OBS, V30, P349, DOI 10.1590/S0100-72032008000700005
- BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x
- Brasiliense DM, 2016, J INFECT DEV COUNTR, V10, P134, DOI 10.3855/jidc.6474
- Cevenini R, 2002, BEST PRACT RES CL OB, V16, P761, DOI 10.1053/beog.2002.0323
- Chernesky M, 2014, J CLIN MICROBIOL, V52, P2305, DOI 10.1128/JCM.03552-13
- Conejero C, 2013, REV CHIL INFECTOL, V30, P489, DOI 10.4067/S0716-10182013000500004
- Machado MSC, 2012, BRAZ J INFECT DIS, V16, P188, DOI 10.1590/S1413-86702012000200015
- de Codes Jose Santiago, 2006, Cad Saude Publica, V22, P325
- Ejegod DM, 2018, PAPILLOMAVIRUS RES, V5, P192, DOI 10.1016/j.pvr.2018.04.005
- Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30
- Falk L, 2010, INT J STD AIDS, V21, P283, DOI 10.1258/ijsa.2009.009440
- Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010
- Fernandes AMS, 2009, REV BRAS GINECOL OBS, V31, P1
- Fonseca AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133635
- Gopalkrishna V, 2000, CLIN MICROBIOL INFEC, V6, P88, DOI 10.1046/j.1469-0691.2000.00024.x
- Guimaraes EMB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-8
- INCA. Instituto Nacional do Cancer Jose Gomes Alencar da Silva, 2016, EST 2016 INC CANC BR, P124
- Jalil EM, 2008, REV BRAS GINECOL OBS, V30, P614, DOI 10.1590/S0100-72032008001200005
- Luppi Carla Gianna, 2011, Rev. bras. epidemiol., V14, P467, DOI 10.1590/S1415-790X2011000300011
- Mishori R, 2012, AM FAM PHYSICIAN, V86, P1127
- Gama ASM, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00002817
- Neves D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00101015
- Piazzetta RCPS, 2011, REV BRAS GINECOL OBS, V33, P328, DOI 10.1590/S0100-72032011001100002
- Paudyal P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124310
- Rocha DAP, 2014, INT J STD AIDS, V25, P878, DOI 10.1177/0956462414523742
- Price MJ, 2016, HEALTH TECHNOL ASSES, V20, P282
- Santos Cristina, 2003, Braz J Infect Dis, V7, P91, DOI 10.1590/S1413-86702003000200001
- Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003
- Snijders PJF, 2013, INT J CANCER, V132, P2223, DOI 10.1002/ijc.27790
- Tranberg M, 2018, CLIN EPIDEMIOL, V10, P1027, DOI 10.2147/CLEP.S164826
- Tranberg M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3254-y
- Witkin SS, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00203-17, 10.1128/cvi.00203-17]